These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12176468)

  • 21. Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563.
    Langrehr JM; Lohmann R; Raakow R; Jonas S; Klupp J; Bechstein WO; Neuhaus R; Neuhaus P
    Transplant Proc; 2001 May; 33(3):2290-1. PubMed ID: 11377531
    [No Abstract]   [Full Text] [Related]  

  • 22. Tacrolimus is effective in both dual and triple regimens after liver transplantation.
    Serrano J; García González M; Gómez M; Ortiz de Urbina J; López Cillero P; San Juan F; Parrilla P; Herrero JI
    Transplant Proc; 2002 Aug; 34(5):1529-30. PubMed ID: 12176469
    [No Abstract]   [Full Text] [Related]  

  • 23. Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation.
    Samuel D; Bismuth H; Boillot O; Ducerf C; Baulieux J; Gugenheim J; Baldini E; Launois B; Messner M; Wolf P; Ellero E; Domergue J; Pageaux J; Cherqui D; Duvoux C; Durand F; Belghiti J; Calmus Y; Massault PP; Neau-Cransac M; Saric J; LeTreut Y; Campan P
    Transplant Proc; 1998 Jun; 30(4):1394-6. PubMed ID: 9636563
    [No Abstract]   [Full Text] [Related]  

  • 24. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
    Sterneck M; Fischer L; Gahlemann C; Gundlach M; Rogiers X; Broelsch C
    Ann Transplant; 2000; 5(1):43-6. PubMed ID: 10850611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low rejection rate after hepatic transplantation achieved with a cyclosporine-based quadruple immunosuppressive regimen.
    Ott R; Gralka S; Froschauer R; Born G; Müller V; Reck T; Hohenberger W; Köckerling F
    Transplant Proc; 1998 Jun; 30(4):1427-9. PubMed ID: 9636578
    [No Abstract]   [Full Text] [Related]  

  • 26. Tacrolimus therapy for ABO-incompatible kidney transplantation.
    Takahashi K; Saito K; Sonda K; Nakagawa Y; Katagiri A; Tomita Y; Tanigawa T; Takeda M
    Transplant Proc; 1998 Jun; 30(4):1219-20. PubMed ID: 9636495
    [No Abstract]   [Full Text] [Related]  

  • 27. Corticosteroid-free therapy after tacrolimus-based dual immunosuppression versus cyclosporine-based quadruple-induction therapy.
    Jonas S; Guckelberger O; Tullius SG; Steinmüller T; Müller AR; Grauhan O; Langrehr JM; Bechstein WO; Neuhaus P
    Transplant Proc; 2001 May; 33(3):2232-3. PubMed ID: 11377511
    [No Abstract]   [Full Text] [Related]  

  • 28. Low incidence of acute rejection in kidney grafts treated with initial quadruple therapy: a retrospective analysis comparing two ATGs.
    Civati G; Minetti E; Busnach G; Perego A; Brando B; Broggi ML; Sansalone V; Forti D
    Transplant Proc; 1998 Jun; 30(4):1343-5. PubMed ID: 9636546
    [No Abstract]   [Full Text] [Related]  

  • 29. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients.
    Marcus N; Khaghani A; Burke M; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460
    [No Abstract]   [Full Text] [Related]  

  • 30. One-year follow-up of a Brazilian randomized multicenter study comparing tacrolimus versus cyclosporine in kidney transplantation.
    Campos HH; Abbud Filho M;
    Transplant Proc; 2002 Aug; 34(5):1656-8. PubMed ID: 12176523
    [No Abstract]   [Full Text] [Related]  

  • 31. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
    Forsythe J
    Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049
    [No Abstract]   [Full Text] [Related]  

  • 32. Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation.
    Fischer S; Hopkinson D; Cassivi SD; Saad S; Paul A
    Transplant Proc; 2000 Dec; 32(8):2817-9. PubMed ID: 11134815
    [No Abstract]   [Full Text] [Related]  

  • 33. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
    Reggiani P; Rossi G; Latham L; Caccamo L; Gatti S; Maggi U; Melada E; Paone G; Doglia M; Vannelli A; Fassati LR
    Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
    [No Abstract]   [Full Text] [Related]  

  • 34. Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience.
    Rossi G; Reggiani P; Orsenigo R; Leoni L; Caccamo L; Doglia M; Gatti S; Maggi U; Paone G; Galmarini D; Fassati LR
    Transplant Proc; 1998 Jun; 30(4):1391-3. PubMed ID: 9636562
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral vs intravenous tacrolimus-based induction therapy in renal transplantation.
    Tojimbara T; Kimikawa M; Nakajima I; Sato S; Nakamura M; Ishida H; Tanabe K; Koyama I; Utsumi K; Sannomiya A; Tsuji K; Fuchinoue S; Agishi T
    Transplant Proc; 1999 Nov; 31(7):2763-4. PubMed ID: 10578282
    [No Abstract]   [Full Text] [Related]  

  • 36. Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
    Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW
    Transplant Proc; 1998 Jun; 30(4):1401-2. PubMed ID: 9636566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipid changes in liver transplantation: effect of steroids withdrawn in a prospective randomized trial under cyclosporine A therapy.
    De Carlis L; Belli LS; Colella G; Rondinara GF; Slim AO; Alberti A; Aseni P; Sansalone CV; Pirotta V; Di Benedetto F; Forti D
    Transplant Proc; 1999; 31(1-2):391-3. PubMed ID: 10083156
    [No Abstract]   [Full Text] [Related]  

  • 38. Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression.
    Ringe B; Braun F; Wietzke P; Oellerich M; Ramadori G
    Transplant Proc; 2000 Nov; 32(7):2543. PubMed ID: 11120285
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of dual versus triple tacrolimus-based therapy in kidney transplantation: two-year follow-up.
    Garcia I;
    Transplant Proc; 2002 Aug; 34(5):1638-9. PubMed ID: 12176516
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of FK506 as primary or rescue therapy after liver transplantation in Hong Kong.
    Lo CM; Fan ST; Liu CL; Chan KL; Ng IO; Lai CL; Lau GK; Fung SK; Wong J
    Transplant Proc; 1998 Nov; 30(7):3587-8. PubMed ID: 9838571
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.